We are live on ! Find out more
EYEGW

Eyegate Pharmaceuticals, Inc. Warrants
EYEGW

Delisted

EYEGW was delisted on the 5th of August, 2020.

Back to rankings

5 hedge funds and large institutions have $377K invested in Eyegate Pharmaceuticals, Inc. Warrants in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$247K
2
AIC
AWM Investment Company
New York
+$169K
3
ICM
Ionic Capital Management
New York
+$34.4K
4
BA
BlackRock Advisors
Delaware
+$7.3K
5
VIA
Vantage Investment Advisors
Pennsylvania
+$3.09K

Top Sellers

No sellers this quarter

EYEGW Hedge Fund Activity: Q3 2015 in Review

5 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) for Q3 2015, worth a combined $377K.

Buyers outnumbered sellers: 5 funds opened new EYEGW positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $247K.

  • 5 institutional investors held Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) as of Q3 2015, up from 0 in Q2 2015.
  • Funds reported $377K of Eyegate Pharmaceuticals, Inc. Warrants stock for Q3 2015.
  • 5 funds opened new Eyegate Pharmaceuticals, Inc. Warrants positions in Q3 2015 and 0 closed out, a net change of +5 holders.
  • The largest Eyegate Pharmaceuticals, Inc. Warrants buyer in Q3 2015 was Sabby Management, an estimated $247K added.

Based on aggregated 13F filings for Q3 2015.